When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Última revisão: 15 Nov 2025
Última atualização: 12 Feb 2025

Resumo

Definição

História e exame físico

Principais fatores diagnósticos

  • reduced urine production
  • vomiting
  • dizziness
  • orthopnea
  • paroxysmal nocturnal dyspnea
  • pulmonary edema
  • hypotension
  • tachycardia
  • orthostatic hypotension
  • hypertension
  • peripheral edema
  • muscle tenderness
  • limb ischemia
  • seizures
  • prostatic obstructive symptoms
  • hematuria
  • fever
  • rash
  • arthralgia/arthritis
  • altered mental status
  • signs of uremia

Outros fatores diagnósticos

  • nausea
  • thirst
  • flank pain
  • abdominal distention
  • abdominal bruit
  • livedo reticularis
  • petechiae
  • ecchymoses

Fatores de risco

  • advanced age
  • underlying renal disease
  • malignant hypertension
  • diabetes mellitus
  • myeloproliferative disorders, such as multiple myeloma
  • connective tissue disease
  • sodium-retaining states (e.g., congestive heart failure, cirrhosis, nephrotic syndrome)
  • radiocontrast
  • exposure to nephrotoxins (e.g., aminoglycosides, vancomycin + piperacillin-tazobactam, cancer therapies, nonsteroidal anti-inflammatory drugs, or ACE inhibitors)
  • trauma
  • hemorrhage
  • sepsis
  • pancreatitis
  • drug overdose
  • surgery
  • cardiac arrest
  • recent vascular intervention
  • excessive fluid loss
  • nephrolithiasis
  • drug abuse
  • alcohol abuse
  • excessive exercise
  • recent blood transfusion
  • malignancy
  • genetic susceptibility
  • use of renin-angiotensin system inhibitors
  • proton pump inhibitors
  • herbal therapy

Investigações diagnósticas

Primeiras investigações a serem solicitadas

  • basic metabolic profile (including blood urea nitrogen [BUN] and creatinine)
  • ratio of serum BUN to creatinine
  • urinalysis
  • urine culture
  • complete blood count
  • fractional excretion of sodium
  • fractional excretion of urea
  • urinary eosinophil count
  • venous blood gases
  • fluid challenge
  • bladder catheterization
  • urine osmolality
  • urine sodium concentration
  • renal ultrasound
  • chest x-ray
  • ECG

Investigações a serem consideradas

  • antinuclear antibodies
  • anti-DNA
  • complement (C3, C4, CH50)
  • anti-glomerular basement membrane antibodies
  • antineutrophil cytoplasmic antibodies
  • acute hepatitis profile
  • HIV serology
  • cryoglobulins
  • erythrocyte sedimentation rate
  • antistreptolysin-O antibody
  • abdominal computed tomography or magnetic resonance imaging scan
  • nuclear renal flow scan
  • cystoscopy
  • renal biopsy

Novos exames

  • novel serum and urinary biomarkers

Algoritmo de tratamento

Colaboradores

Consultores especialistas

Richard A. Lafayette, MD

Professor of Medicine

Nephrology Division

Stanford University Medical Center

Stanford

CA

Declarações

RAL works as a consultant and researcher for Relypsa, Inc. Although unrelated to this topic area, RAL also works as a consultant for Fibrogen, Inc., Mallinckrodt, Inc., and Omeros, Inc., and as a researcher for Genentech, Inc., Mallinckrodt, Inc., GlaxoSmithKline, Inc., Rigel, Inc., Aurinia, Inc., and the NIH.

Agradecimentos

Dr Richard A. Lafayette would like to gratefully acknowledge Dr Sandra Sabatini, Dr Neil Kurtzman, and Dr Corey D. Ball, the previous contributors to this topic.

Declarações

SS, NK, and CDB declare that they have no competing interests.

Revisores

Garabed Eknoyan, MD

Professor of Medicine

Section of Nephrology

Department of Medicine

Baylor College of Medicine

Houston

TX

Declarações

GE declares that he has no competing interests.

Dominic de Takats, MA, MRCP

Consultant Nephrologist

Nephrology

North Staffs Royal Infirmary

University Hospital of North Staffordshire

Stoke-on-Trent

UK

Declarações

DdT declares that he has no competing interests.

Créditos aos pareceristas

Os tópicos do BMJ Best Practice são constantemente atualizados, seguindo os desenvolvimentos das evidências e das diretrizes. Os pareceristas aqui listados revisaram o conteúdo pelo menos uma vez durante a história do tópico.

Declarações

As afiliações e declarações dos pareceristas referem--se ao momento da revisão.

Referências

Nossas equipes internas de editoria e de evidências trabalham em conjunto com colaboradores internacionais especializados e pares revisores para garantir que forneçamos acesso às informações o mais clinicamente relevantes possível.

Principais artigos

Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl. 2012 Mar;2(1):1-138.Texto completo

Palevsky PM, Liu KD, Brophy PD, et al. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for acute kidney injury. Am J Kidney Dis. 2013 May;61(5):649-72.Texto completo  Resumo

Moore PK, Hsu RK, Liu KD. Management of acute kidney injury: core curriculum 2018. Am J Kidney Dis. 2018 Jul;72(1):136-48.Texto completo  Resumo

Artigos de referência

Uma lista completa das fontes referenciadas neste tópico está disponível aqui.

O uso deste conteúdo está sujeito ao nosso aviso legal